Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up0.55% Nasdaq Up0.29%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
13.91 0.15(1.07%) Apr 15, 4:00PM EDT
Get the big picture on all your investments.
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):1.6
Mean Recommendation (last week):1.6
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:25.64
Median Target:25.00
High Target:34.00
Low Target:19.00
No. of Brokers:11

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Mar 21, 2014MizuhoInitiated Buy
Dec 13, 2012Maxim GroupInitiated Buy
Nov 13, 2012Burrill Institutional ResearchInitiated Mkt Outperform
May 10, 2012Ladenburg ThalmannUpgradeNeutralBuy
Apr 3, 2012Ladenburg ThalmannDowngradeBuyNeutral
May 17, 2011OppenheimerInitiated Outperform
May 6, 2011MLV CapitalInitiated Buy
Mar 16, 2011JMP SecuritiesInitiated Mkt Outperform
Mar 1, 2010Rodman & RenshawInitiated Mkt Outperform
Feb 25, 2010Roth CapitalInitiated Buy

More Upgrades & Downgrades for KERX

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy4444
Buy6666
Hold0000
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.